Lyell syndrome revisited: Analysis of 18 cases of severe bullous skin disease in a burns unit

British Journal of Plastic Surgery

Volumn 58, Issue 1, 2005, Pages 73-80

  Neff, Phillip ^a   Meuli Simmen, C ^b   Kempf, W ^c   Gaspert, T ^a   Meyer, V E ^a   Kunzi W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bullous skin disease; Interdisciplinary treatment; Intravenous immunoglubulins; Paraneoplastic pemphigus; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORAL HYDRATE; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DICLOFENAC; IMMUNOGLOBULIN; PHENYTOIN;

ADULT; AGED; BULLOUS SKIN DISEASE; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ERUPTION; FEMALE; HEALTH CARE FACILITY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; MALE; MORTALITY; PARANEOPLASTIC SYNDROME; PATIENT REFERRAL; PITYRIASIS LICHENOIDES; PLASTIC SURGERY; PRIORITY JOURNAL; PUSTULOSIS; RETROSPECTIVE STUDY; REVIEW; SWITZERLAND; TOXIC EPIDERMAL NECROLYSIS; UNIVERSITY HOSPITAL;

EID: 11844294705     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2004.04.025     Document Type: Article

References (40)

1. Roujeau J.C. Guillaume J.C. Fabre J.P. Penso D. Fléchet M.L. Girre J.P. Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981-1985 Arch Dermatol 126 1990 37-42
2. Chan H.L. Stern R.S. Arndt K.A. et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis Arch Dermatol 126 1990 43-47
3. Schöpf E. Stühmer A. Rzany B. Victor N. Zentgraf R. Kapp J.F. Toxic epidermal necrolysis an Stevens-Johnson syndrome. An epidemiologic study from West Germany Arch Dermatol 127 1991 839-842
4. Saiag P. Caumes E. Chosidow O. Revuz J. Roujeau J.C. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus J Am Acad Dermatol 26 1992 567-574
5. Correia O. Chosidow O. Saiag P. Bastuji-Garin S. Revuz J. Roujeau J.C. Evolving pattern of drug-induced toxic epidermal necrolysis Dermatology 186 1993 32-37
6. Roujeau J.C. Revuz J. Toxic epidermal necrolysis: An expanding field of knowledge J Am Acad Dermatol 31 1994 301-302
7. Correia O. Delgado L. Santos C. Miranda A.M. HIV-1 in blister fluid of a patient with toxic epidermal necrolysis an AIDS Lancet 344 1994 1432-1433
8. Peters W. Zaidi J. Douglas L. Toxic epidermal necrolysis: A burn-centre challenge Can Med Assoc J 144 1991 1477-1480
9. Kelemen J. Cioffi W. McManus W. Mason A. Pruitt B. Burn center care for patients with toxic epidermal necrolysis J Am Coll Surg 180 1995 273-278
10. McGee T. Munster A. Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn center Plast Reconst Surg 102 1998 1018-1022
11. Schulz J. Sheridan R. Ryan C. MacKool B. Tompkins R. A 10-year experience with toxic epidermal necrolysis J Burn Care Rehabil 21 2000 199-204
12. Lyell A. Toxic epidermal necrolysis: An eruption resembling scalding of the skin Br J Dermatol 68 1956 355-361
13. Wolkenstein P. Roujeau J.C. Revuz J. Drug-induced toxic epidermal necrolysis Clin Dermatol 16 1998 399-409
14. Stevens A.M. Johnson F.C. A new eruptive fever associated with stomatitis an ophthalmia: Report of two cases in children Am J Dis Child 24 1922 526-533
15. Bastuji-Garin S. Rzani B. Stern R.S. Shear N.H. Naldi L. Roujeau J.C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 1993 92-96
16. Roujeau J.C. Kelly J. Naldi L. et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 333 1995 1600-1607
17. Auquier-Dunant A. Mockenhaupt M. Naldi L. Correia O. Schröder W. Roujeau J.C. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis Arch Dermatol 138 2002 1019-1024
18. Lyell A. Dick H.M. Alexander J.D. Outbreak of toxic epidermal necrolysis associated with staphylococci Lancet 1 1969 787-790
19. Melish M.E. Glasgow L.A. The staphylococcal scalded-skin syndrome: development of an experimental model N Engl J Med 282 1970 1114-1119
20. Rzany B. Hering O. Mockenhaupt M. et al. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis Br J Dermatol 135 1996 6-11
21. Coté B. Wechsler J. Bastuji-Garin S. Assier H. Revuz J. Roujeau J.C. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome Arch Dermatol 131 1995 1268-1272
22. Assier H. Bastuji-Garin S. Revuz J. Roujeau J.C. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes Arch Dermatol 131 1995 539-543
23. Fine J. Management of acquired bullous skin diseases N Engl J Med 333 1995 1475-1484
24. Becker D.S. Toxic epidermal necrolysis Lancet 351 1998 1417-1420
25. Atiyeh B.S. Kayle D.I. Nasser A.A. Burn-like syndromes Ann Burns Fire Disasters 12 1999 39-42
26. Revuz J. Roujeau J.C. Guillaume J.C. Penso D. Touraine R. Treatment of toxic epidermal necrolysis. Creteil's experience Arch Dermatol 123 1987 1156-1158
27. Halebian P. Madden M. Finklestein J. Corder V. Shires G. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids Ann Surg 204 1986 503-512
28. Paul C. Wolkenstein P. Adle H. et-al Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis Br J Dermatol 134 1996 710-714
29. Viard I. Wehrli P. Bullani R. et-al Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490-493
30. Roujeau J.C. Huynh T. Bracq C. Guillaume J.C. Revuz J. Touraine R. Genetic susceptibility to toxic epidermal necrolysis Arch Dermatol 123 1987 1171-1173
31. Yanaba K. Ito M. Sasaki H. et al. A case of febrile ulceronecrotic Mucha-Habermann disease requiring debridement of necrotic skin and epidermal autograft Br J Dermatol 147 2002 1249-1253
32. Avakian R. Flowers F. Araujo O. Ramos-Caro F. Toxic epidermal necrolysis: A review J Am Acad Dermatol 25 1991 69-79
33. Roujeau J.C. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classification J Invest Dermatol 102 1994 28S-30S
34. Stone S. Schroeter A. Bullous pemphigoid and associated malignant neoplasms Arch Dermatol 111 1975 991-994
35. Mutasim D. Pelc N. Anhalt G. Paraneoplastic pemphigus Dermatol Clin 11 1993 473-481
36. Anhalt G. Kim S. Stanley J. et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia N Engl J Med 323 1990 1729-1735
37. Anhalt G. Paraneoplastic pemphigus Adv Dermatol 12 1997 77-96
38. Norris D. Saywell M. Strutton G. Stephenson G. Pemphigus vulgaris associated with spindle cell thymoma Australas J Dermatol 34 1993 97-102
39. Leyn J. Degreef H. Paraneoplastic pemphigus an a patient with a thymoma Dermatology 202 2001 151-154
40. Lyon C. Carmichael A. Toxic epidermal necrolysis and paraneoplastic pemphigus Lancet 352 1998 149